Inventor · disambiguated record
Daisuke Nishimiya
Also filed as: NISHIMIYA DAISUKE
11 granted patents·8 pending applications·11 citations·filing 2012–2024
85Inventor score
Top patents by PatentIndex Score
19 records- 0189US11292828B2KLK5 inhibitory peptideDAIICHI SANKYO CO LTD·Filed 2021·Granted Apr 5, 2022·2 cites·29 claims
- 0287US11845786B2Peptides inhibiting KLK1, KLK4, or KLK4 and KLK8DAIICHI SANKYO CO LTD·Filed 2021·Granted Dec 19, 2023·1 cites·23 claims
- 0387US10550154B2Peptide library and use thereofDAIICHI SANKYO CO LTD·Filed 2013·Granted Feb 4, 2020·5 cites·12 claims
- 0487US2025042947A1Peptide library and use thereofDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 0583US11319345B2Peptide library and use thereofDAIICHI SANKYO CO LTD·Filed 2020·Granted May 3, 2022·1 cites·16 claims
- 0680US11208467B2Peptides inhibiting KLK1, KLK4, or KLK4 and KLK8DAIICHI SANKYO CO LTD·Filed 2018·Granted Dec 28, 2021·1 cites·24 claims
- 0780US2024360200A1Klk5 inhibitory peptideDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 0878US2024294610A1Peptide for treating age-related macular degenerationDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 0977US2022372076A1Peptide library and use thereofDAIICHI SANKYO CO LTD·Filed 2022·Application pending·0 cites
- 1076US12024547B2KLK5 inhibitory peptideDAIICHI SANKYO CO LTD·Filed 2022·Granted Jul 2, 2024·0 cites·23 claims
- 1175US12043658B2Conjugate comprising an active MMP-9-binding peptideDAIICHI SANKYO CO LTD·Filed 2022·Granted Jul 23, 2024·0 cites·18 claims
- 1274US11926655B2Active MMP9-binding peptideDAIICHI SANKYO CO LTD·Filed 2018·Granted Mar 12, 2024·1 cites·9 claims
- 1371US11060108B2DNA element having the activity of enhancing foreign gene expressionDAIICHI SANKYO CO LTD·Filed 2019·Granted Jul 13, 2021·0 cites·22 claims
- 1467US2021032313A1Klk5 inhibitory peptideDAIICHI SANKYO CO LTD·Filed 2020·Application pending·0 cites
- 1564US9371543B2DNA element having the activity of enhancing foreign gene expressionDAIICHI SANKYO CO LTD·Filed 2012·Granted Jun 21, 2016·0 cites·30 claims
- 1663US10407694B2DNA element having the activity of enhancing foreign gene expressionDAIICHI SANKYO CO LTD·Filed 2016·Granted Sep 10, 2019·0 cites·26 claims
- 1760US2024247066A1Structure based isolation of pmhc-restricted antibodiesUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 1854US2020377573A1Peptide for treating age-related macular degenerationDAIICHI SANKYO CO LTD·Filed 2017·Application pending·0 cites
- 1946US2022002385A1Method of improving blood kinetics of peptideDAIICHI SANKYO CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daisuke Nishimiya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →